Venrock has raised $400 million for its Venrock Healthcare Capital Partners III cross-over biotech fund, according to an SEC filing posted this week. The total funds raised include a commitment from Venrock’s general partner, VHCP Management III, according to the SEC filing. Venrock has not yet released any detailed plans on how it will spend […]
Venrock
Medtech investment in MN falls back to earth | Medtech funding for the week of April 20, 2015
Spirox lands $19m Series B round
Spirox said this week that it nailed down an $18.5 million Series B round to back development and commercialization of its device to treat patients with nasal obstructions.
Venrock and Aisling Capital led the round for Menlo Park, Calif.-based Spirox, with existing investors Aperture Venture Partners, Correlation Ventures and Western Technology Investment also participating.
PowerVision gains $30 million in funding round | Medtech funding for the week of June 16, 2014
PowerVision raises $30M for FluidVision implantable lens
Ophthalmic devices maker PowerVision finally put a ribbon on its $30 million Series D funding round, planning on using the funds to advance clinical trials in support of regulatory approvals in Europe and the U.S.
DOD hands out $99.6 million in contracts to Hologic, GE, PositiveID | Medtech funding stories for the week of Apr. 7, 2014
Cancer: RefleXion Medical raises $11.6M to ‘make radiotherapy personal’
California-based medtech group RefleXion Medical touted an $11.6 million Series A fundraising round, hoping to use the new funds to expand research & development efforts for its guided radiation therapy technology.
Venrock puts together a $350 million fund
Jumping on the venture capital industry’s less-is-more bandwagon, Venrock put together a $350 million fund, down more than 40 percent from its last funding pool.
